only pediatric patients, included specimens collected by rectal swabbing, and used a different Shiga toxin assay (5) . Investigators disagree on the sensitivities of Shiga toxin assay and SMAC for detection of STEC. Kehl et al. reported superior sensitivity of Shiga toxin assay for detection of serotype 0157:H7 compared to SMAC (100 versus 60%, respectively) (4). Decisions can and should be made by local experts using local data. (ii) Is O157:H7 more pathogenic than other serotypes of STEC? In our 29 cases, patients were as likely to have severe disease regardless of serotype. In addition, non-O157:H7 serotypes were the etiologies in more than 50% of our patients. Similarly, reports from around the world document increasing prevalence and pathogenicity of non-O157:H7 strains (1, 2). In contrast, non-O157 serotypes were responsible for a small minority of disease in the pediatric population described by Klein et al. (5), again emphasizing differences among patient populations and the importance of local knowledge. (iii) Is a delay in culture of 1 day a clinical liability? We perform toxin testing daily, providing results to clinicians as quickly as, or more quickly than, SMAC culture. (iv) Is a delay of 1 day before the isolate is forwarded to the public health laboratory unacceptable? Our public health laboratory is notified the same day a toxin assay is positive. The O157:H7 strain would be forwarded the following day. At this time, our public health laboratory no longer accepts non-O157:H7 strains, will not accept Shiga toxin-positive stools negative for O157:H7 for testing, and is not open Saturday and Sunday. Thus, in practice, in our population, a 1-day delay introduced by sequential rather than concurrent culture is less important than other public health issues existing with reporting of this disease.
We appreciate the close scrutiny and thoughtful suggestions provided by Klein et al. Our screening strategy was shown to significantly expand the detection of adult and pediatric patients with infection caused by STEC. Whether this strategy is applicable in other populations must be determined locally, as stated in our discussion. Once again, we all agree that expanded, timely testing by more laboratories is needed and that a comprehensive approach to STEC testing should include a Shiga toxin assay. Whether or not a sorbitol MacConkey agar plate is used can be determined by local data and experts.
